These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection. Chi CT; Chau GY; Lee RC; Chen YY; Lei HJ; Hou MC; Chao Y; Huang YH J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):125-133. PubMed ID: 30876788 [TBL] [Abstract][Full Text] [Related]
24. Loss of the orphan nuclear receptor SHP is more pronounced in fibrolamellar carcinoma than in typical hepatocellular carcinoma. Wilczek E; Szparecki G; Lukasik D; Koperski L; Winiarska M; Wilczynski GM; Wasiutynski A; Gornicka B PLoS One; 2012; 7(1):e30944. PubMed ID: 22292081 [TBL] [Abstract][Full Text] [Related]
25. A genomic case study of mixed fibrolamellar hepatocellular carcinoma. Griffith OL; Griffith M; Krysiak K; Magrini V; Ramu A; Skidmore ZL; Kunisaki J; Austin R; McGrath S; Zhang J; Demeter R; Graves T; Eldred JM; Walker J; Larson DE; Maher CA; Lin Y; Chapman W; Mahadevan A; Miksad R; Nasser I; Hanto DW; Mardis ER Ann Oncol; 2016 Jun; 27(6):1148-1154. PubMed ID: 27029710 [TBL] [Abstract][Full Text] [Related]
26. Update on hepatocellular carcinoma: Pathologists' review. El Jabbour T; Lagana SM; Lee H World J Gastroenterol; 2019 Apr; 25(14):1653-1665. PubMed ID: 31011252 [TBL] [Abstract][Full Text] [Related]
27. Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma. Ishii T; Ito T; Sumiyoshi S; Ogiso S; Fukumitsu K; Seo S; Taura K; Uemoto S World J Surg Oncol; 2020 Dec; 18(1):319. PubMed ID: 33276780 [TBL] [Abstract][Full Text] [Related]
28. Response to Loco-Regional Therapy Predicts Outcomes After Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma. Antwi SO; Habboush YY; Chase LA; Lee DD; Patel T Ann Hepatol; 2018 Oct; 17(6):969-979. PubMed ID: 30600299 [TBL] [Abstract][Full Text] [Related]
29. Genomic characterization of rare molecular subclasses of hepatocellular carcinoma. Damrauer JS; Smith MA; Walter V; Thennavan A; Mose LE; Selitsky SR; Hoadley KA Commun Biol; 2021 Oct; 4(1):1150. PubMed ID: 34608257 [TBL] [Abstract][Full Text] [Related]
30. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning? Liu X; Khalvati F; Namdar K; Fischer S; Lewis S; Taouli B; Haider MA; Jhaveri KS Eur Radiol; 2021 Jan; 31(1):244-255. PubMed ID: 32749585 [TBL] [Abstract][Full Text] [Related]
32. Differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in high-risk patients matched to MR field strength: diagnostic performance of LI-RADS version 2018. Zou X; Luo Y; Morelli JN; Hu X; Shen Y; Hu D Abdom Radiol (NY); 2021 Jul; 46(7):3168-3178. PubMed ID: 33660040 [TBL] [Abstract][Full Text] [Related]
33. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver. Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708 [TBL] [Abstract][Full Text] [Related]
34. Challenges of Clinical Research on Hepatocellular Carcinoma. Kudo M; Kitano M; Sakurai T; Nishida N Dig Dis; 2015 Oct; 33(6):780-90. PubMed ID: 26488399 [TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma. Likhitrattanapisal S; Tipanee J; Janvilisri T Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818 [TBL] [Abstract][Full Text] [Related]
36. Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports. Al Zahrani A; Alfakeeh A J Med Case Rep; 2021 Mar; 15(1):132. PubMed ID: 33722275 [TBL] [Abstract][Full Text] [Related]
37. Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis. Lin CW; Wu TC; Lin HY; Hung CM; Hsieh PM; Yeh JH; Hsiao P; Huang YL; Li YC; Wang YC; Shu CW; Chen YS BMC Gastroenterol; 2021 Jan; 21(1):20. PubMed ID: 33413162 [TBL] [Abstract][Full Text] [Related]
38. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management. Shanbhogue AK; Prasad SR; Takahashi N; Vikram R; Sahani DV Radiology; 2011 Mar; 258(3):673-93. PubMed ID: 21339346 [TBL] [Abstract][Full Text] [Related]
39. Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor. Garancini M; Goffredo P; Pagni F; Romano F; Roman S; Sosa JA; Giardini V Liver Transpl; 2014 Aug; 20(8):952-9. PubMed ID: 24777610 [TBL] [Abstract][Full Text] [Related]
40. Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors. Ward SC; Waxman S Semin Liver Dis; 2011 Feb; 31(1):61-70. PubMed ID: 21344351 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]